Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study (2026)
Subjects: ESTUDOS RETROSPECTIVOS, HOSPITAIS PÚBLICOS, HEPATOPATIAS, BIOMARCADORES
ABNT
PEREIRA, Isabel Veloso Alves et al. Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study. Clinics, v. 80, 2026Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/90858. Acesso em: 01 maio 2026.APA
Pereira, I. V. A., Oliveira, A. B. S. de, Zitelli, P. M. Y., Barbieri, L. A., Cardoso, A. C., Monteiro, M. J. de S. D., et al. (2026). Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study. Clinics, 80. doi:10.1016/j.clinsp.2025.100737NLM
Pereira IVA, Oliveira ABS de, Zitelli PMY, Barbieri LA, Cardoso AC, Monteiro MJ de SD, Oliveira JS de, Stefano JT, Altikes R, Oliveira CPMS de. Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study [Internet]. Clinics. 2026 ; 80[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90858Vancouver
Pereira IVA, Oliveira ABS de, Zitelli PMY, Barbieri LA, Cardoso AC, Monteiro MJ de SD, Oliveira JS de, Stefano JT, Altikes R, Oliveira CPMS de. Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study [Internet]. Clinics. 2026 ; 80[citado 2026 maio 01 ] Available from: https://observatorio.fm.usp.br/handle/OPI/90858
